Hasta La Creative!

Bayer was ordered to run corrective advertising for one of its brands. The FDA and 27 state attorneys general ordered Bayer to produce a six-month, $20 million corrective-advertising campaign for Yaz, the German pharma company’s birth-control pill. It began in late January and is scheduled to end July 26.

The FDA ruled that Bayer’s marketing and advertising for Yaz was deceptive and made false claims regarding its efficacy for acne and premenstrual syndrome. In a statement, Illinois Attorney General Lisa Madigan, who crafted the terms of the agreement with two other attorneys general and the FDA, said, “This settlement reflects the continual monitoring my office performs to ensure the pharmaceutical industry is not using deceptive marketing and advertising practices.”

(Source) Ad Age